Validation of a von Willebrand factor - Factor VIII binding assay to characterise atypical phenotypes of apparent Haemophilia A

New Zealand Journal of Medical Laboratory Science

Volumn 57, Issue 1, 2003, Pages 12-15

  Allan, Karen L ^a   Patterson, David M ^a   Smith, Mark P ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

ELISA; Factor VIII; Factor VIII binding assay; Type 2N von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOPHILIA A; HUMAN; PROTEIN BINDING; STANDARDIZATION; VALIDATION PROCESS;

EID: 0038035339     PISSN: 11710195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand disease. Blood 1987; 69: 454-9.
2. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
3. Nishino M, Girma JP, Rotschild C, Fressinaud E, Meyer D. A new variant of von Willebrand disease with defective binding to factor VIII. Blood 1989; 74: 1591-9.
4. Mazurier C, Dieval J, Jorieux S, Delobel J, Goudemand M. A new von Willebrand factor (vWF) defect in a patient with factor VIII deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 1990; 75: 20-6.
5. Mazurier C, Gaucher C, Jorieux, S, Parquet-Gernez A, Goudemand M. Evidence for a von Willebrand defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling. Br J Haematol 1990; 76: 372-9.
6. Short PE, Williams CE, Picken AM, Hill FG. Factor VIII related antigen: an improved enzyme immunoassay. Med Lab Sci 1982; 39: 351-5.
7. Favaloro EJ, Smith J, Petinos P, Collecutt M, Street A, Hertzberg M. Laboratory testing, diagnosis, and management of von Willebrand's disease. Current practice in Australasia. Am J Clin Pathol 1999; 112: 712-9.
8. Miller C, Kelley L, Green D. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor. Am J Hematol 1998; 58: 311-8.
9. Casonato A, Pontara E, Zerbinati P, Zucchetto A, Girolami A. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. Am J Clin Pathol 1998; 109: 347-52.
10. Mazurier C, Meyer D. Factor VIII binding assay of von Willebrand factor and the diagnosis of Type 2N von Willebrand disease - results of an international survey. Thromb Haemost 1996; 76: 270-4.
11. Schneppenheim R, Buddle U, Krey S, Drewke E, Bergmann F, Lechler E, et al. Results of a screening for von Willebrand disease type 2N in patients with suspected Haemophilia A or von Willebrand disease Type 1. Thromb Haemost 1996; 76: 598-602